Related Experiment Video
Updated: May 20, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Infective endocarditis in the pediatric patient: a 60-year single-institution review
Jennifer A Johnson1, Thomas G Boyce, Frank Cetta
1Division of Pediatric Cardiology, Mayo Clinic, Rochester, MN 55905, USA.
Insights
Pediatric infective endocarditis (IE) most often affects children with congenital heart disease. Modern treatment has significantly reduced endocarditis-related mortality compared to earlier eras.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Infective endocarditis (IE) is a serious infection affecting heart valves.
- Pediatric IE epidemiology and outcomes have evolved over time.
- Understanding trends in pediatric IE is crucial for improving patient care.
Purpose of the Study:
- To investigate the epidemiology of pediatric infective endocarditis over a 60-year period.
- To compare contemporary IE cases with a historical cohort.
- To identify risk factors and outcomes in pediatric IE patients.
Main Methods:
- Retrospective review of medical records for pediatric patients diagnosed with IE (1980-2011).
- Comparison with a previously reported cohort (1950-1979).
- Analysis of demographic data, diagnostic variables, and patient outcomes.
Main Results:
- 53 episodes of IE in 47 pediatric patients identified; 77% had congenital heart disease.
- Viridans streptococci and Staphylococcus aureus were the most common pathogens.
- One-year mortality significantly decreased from 38% in the historical cohort to 4% in the modern cohort.
Conclusions:
- Congenital heart disease is a primary risk factor for pediatric IE.
- Significant reduction in mortality for infective endocarditis in children in the modern era.
- Improved outcomes highlight advances in pediatric cardiac care and IE management.
Objective:
To determine the epidemiology of infective endocarditis (IE) presenting in pediatric patients during a 60-year period at our institution.
Patients And Methods:
In this retrospective medical record review, we extracted demographic characteristics, diagnostic variables, and outcomes for patients less than 20 years of age diagnosed with IE from January 1, 1980, to June 30, 2011. We compared this cohort with a previously reported cohort of pediatric patients with IE from our institution diagnosed from 1950 to 1979.
Results:
We identified 47 patients (24 males; mean ± SD age at diagnosis, 12.3±5.5 years [range, 1 day to 18.9 years]) who had 53 episodes of IE. The most common isolated organisms were viridans streptococci (17 of 53 episodes [32%]) and Staphylococcus aureus (12 of 53 episodes [23%]). Of the 47 patients, 36 (77%) had congenital heart disease, 24 of whom had cardiac surgery before their first episode of IE (mean ± SD time to IE diagnosis after surgery, 4.2±3.2 years [range, 64 days to 11.3 years]). Fourteen patients (30%) required valve replacement because of valvular IE, and 16 (34%) had complications, including mycotic aneurysm, myocardial abscess, or emboli. Vegetations were identified using echocardiography in 37 of the 53 unique episodes of IE (70%). Endocarditis-related mortality occurred in 1 patient. Compared with the historical (1950-1979) cohort, there were no differences in patient demographic characteristics, history of congenital heart disease, or infecting organisms. One-year mortality was significantly lower in the modern cohort (4%) compared with the historical cohort (38%) (P<.001).
Conclusion:
Most pediatric episodes of IE occur in patients with congenital heart disease. Mortality due to endocarditis has decreased in the modern era.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies